PYK2, a hub of signaling networks in breast cancer progression
Trends in Cell Biology · 2024-04 · 34 (4) · 312-326
DOI: 10.1016/j.tcb.2023.07.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cell Biology, 2024-04. Verfasst von Hava Gil-Henn und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel. Hauptthemen laut MEDLINE: Breast Neoplasms, Focal Adhesion Kinase 2. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: Agence Nationale pour le Développement de la Recherche Universitaire, Fondation pour la Recherche Médicale, Israel Cancer Research Fund.
Abstract (Originalsprache)
Breast cancer (BC) involves complex signaling networks characterized by extensive cross-communication and feedback loops between and within multiple signaling cascades. Many of these signaling pathways are driven by genetic alterations of oncogene and/or tumor-suppressor genes and are influenced by various environmental cues. We describe unique roles of the non-receptor tyrosine kinase (NRTK) PYK2 in signaling integration and feedback looping in BC. PYK2 functions as a signaling hub in various cascades, and its involvement in positive and negative feedback loops enhances signaling robustness, modulates signaling dynamics, and contributes to BC growth, epithelial-to-mesenchymal transition (EMT), stemness, migration, invasion, and metastasis. We also discuss the potential of PYK2 as a therapeutic target in various BC subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.
- Institut du Fer à Moulin, Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche en Santé (UMRS) 1270, Sorbonne Université, 75005 Paris, France.
- Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: sima.lev@weizmann.ac.il.
Förderung
- Agence Nationale pour le Développement de la Recherche Universitaire
- Fondation pour la Recherche Médicale
- Israel Cancer Research Fund
- Israel Science Foundation
- Deutsches Krebsforschungszentrum
- Agence Nationale de la Recherche
Zitieren
APA
Gil-Henn, H., Girault, J. A., & Lev, S. (2024). PYK2, a hub of signaling networks in breast cancer progression. Trends in Cell Biology, 34(4), 312-326. https://doi.org/10.1016/j.tcb.2023.07.006
Vancouver
Gil-Henn H, Girault JA, Lev S. PYK2, a hub of signaling networks in breast cancer progression. Trends in Cell Biology. 2024;34(4):312-326. doi:10.1016/j.tcb.2023.07.006
BibTeX
@article{GilHenn2024,
author = {Gil-Henn, Hava and Girault, Jean-Antoine and Lev, Sima},
title = {PYK2, a hub of signaling networks in breast cancer progression},
journal = {Trends in Cell Biology},
year = {2024},
volume = {34},
number = {4},
pages = {312--326},
doi = {10.1016/j.tcb.2023.07.006}
}
EUVIMED